Plexus Corp. (NASDAQ:PLXS – Get Free Report) insider Michael Running sold 510 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $272.17, for a total transaction of $138,806.70. Following the completion of the sale, the insider directly owned 665 shares in the company, valued at $180,993.05. This represents a 43.40% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Plexus Price Performance
PLXS traded up $9.28 on Monday, reaching $282.29. The company had a trading volume of 416,459 shares, compared to its average volume of 338,922. The business has a 50 day simple moving average of $245.12 and a 200 day simple moving average of $199.73. The company has a market cap of $7.55 billion, a price-to-earnings ratio of 41.27 and a beta of 0.89. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.54. Plexus Corp. has a 52-week low of $115.35 and a 52-week high of $292.33.
Plexus (NASDAQ:PLXS – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.18. The business had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.13 billion. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The business’s quarterly revenue was up 18.7% on a year-over-year basis. During the same period last year, the business earned $1.66 earnings per share. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. As a group, sell-side analysts anticipate that Plexus Corp. will post 5.98 EPS for the current year.
Institutional Investors Weigh In On Plexus
Analyst Upgrades and Downgrades
PLXS has been the topic of several recent research reports. Zacks Research cut Plexus from a “hold” rating to a “strong sell” rating in a research note on Wednesday, May 20th. Weiss Ratings raised Plexus from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, May 11th. Benchmark reaffirmed a “buy” rating and issued a $220.00 price target on shares of Plexus in a research note on Monday, March 16th. Needham & Company LLC upped their price target on Plexus from $285.00 to $310.00 and gave the stock a “buy” rating in a research note on Monday, June 1st. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $275.00 price target on shares of Plexus in a research note on Thursday, April 30th. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $238.33.
View Our Latest Stock Analysis on Plexus
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Featured Stories
- Five stocks we like better than Plexus
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
